Fidelidade announces 2025 IPO, cancels IPO of subsidiary Luz Saúde

Portuguese insurance company Fidelidade has outlined its plans for a 2025 initial public offering (IPO), following a strategic reassessment that includes the cancellation of the planned listing of its hospital subsidiary, Luz Saúde. The move signals a shift in strategy for Fidelidade, which is majority-owned by China’s Fosun International.

Interview: Katie Tryon, Director of Health Strategy, Vitality

With HBI 2024 fast approaching, we spoke with Katie Tryon, Director of Health Strategy at UK health insurance firm Vitality, about why sustainable healthcare is so important, and key changes and surprises the sector has faced in the last 12 months.

AXA UK acquires HBSUK

Insurance company AXA UK has acquired healthcare services provider HBSUK. It shows how the group is pursuing a wider remit than traditionally expected of insurance companies.

Cigna sells Medicare business for $3.3bn

Last week, US health insurer giant Cigna finally offloaded its Medicare business - which manages government-back health insurance for over 65s - to insurer Health Care Service Corp (HCSC). The $3.3bn cash deal finally putting industry rumours of a megadeal with rival insurer Humana to bed.

Voyage Care names new CEO

A new CEO for Voyage Care - the UK’s largest provider of support for people with learning disabilities by revenue - has been named. The successor is current CCO at UK nursing home operator HC-One, Mike McKessar, who will assume the position early this summer.

Cigna and Humana deal off

Contrary to speculation that a deal would be announced by Christmas, two of the largest health insurers in the US - Cigna and Humana - will not be merging to form a $140bn giant insurer. After reportedly failing to agree on a price, Cigna is instead reportedly planning to buy back $10bn worth of shares.

Cigna and Humana “in talks to merge”

Two of the US’s largest health insurers - Cigna and Humana - are reportedly in talks to merge. A stock-and-cash megadeal could be announced by the end of the year, but any deal will likely attract the interest of the regulator.

Three things we learned at Global Health, Riyadh

HBI attended the Global Health Exhibition in Riyadh, Saudi Arabia, and saw first-hand how the country is changing ahead of its 2030 transformation plan. Here are our three key takeaways from the event.

Find Us